Arrival of CAR-T Immunotherapy Raise Hopes for Treatment and Anxieties About Costs – Cancer Therapy Advisor
Cancer Therapy Advisor |
Arrival of CAR–T Immunotherapy Raise Hopes for Treatment and Anxieties About Costs
Cancer Therapy Advisor CAR-T therapies like CTL019 are “living drugs” produced by removing patients' T cells through leukapheresis, a type of apheresis specific to white blood cells, for genetic modification at an offsite lab, amplification, and reinfusion into the patient. |
